Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (‘Cardiol’ or the ‘Company’), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, is pleased to announce the Company has filed a preliminary prospectus supplement (the ‘Supplement’) to its…
Metals Australia Ltd (ASX: MLS) (“Metals Australia” or “the Company”) is pleased to announce that drilling is set to…
The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) has traded at three-year highs in 2024 in response to looming interest rate cuts,…
Feneck laid out and discussed five points investors should consider when evaluating a junior mining company in order of…
White Cliff Minerals Limited (“the Company”) is delighted to announce the first batch of assay results from rock chip…
Boss Energy Limited (ASX: BOE|OTCQX: BQSSF) is pleased to announce that its 30 per cent-owned Alta Mesa ISR Uranium…
Antilles Gold Limited (“Antilles Gold” or the “Company”) (ASX: AAU, OTCQB: ANTMF) advises that subsequent to the ASX announcement…
Alvopetro Energy Ltd. (TSXV: ALV) (OTCQX: ALVOF) announces September 2024 sales volumes and an operational update. President & CEO,…
Over the last six months, gold has been on an upward trajectory, registering fresh all-time highs nearly every month.…